Table 1. Values of σIE, TΔSIE, TΔSIE, TΔSIE, and IE from Our Previous MM/GBSA Investigations28,31,41,42,50,51 and in the Present Studya.
protein | ligand | length | f | σIE | –TΔSIE | –TΔSC2 | –TΔSNM |
---|---|---|---|---|---|---|---|
lysozyme42 | Bz | 20 × 0.2 | 5 | 6 | 6 | 7 | 52 |
40 × 0.2 | 6 | 18 | 6 | 53 | |||
b | 10 × 10 | 0.01 | 6 | 15 | 6 | ||
b | 10 × 100 | 10 | 6 | 14 | 7 | ||
ferritin31 | L1 | 40 × 1.2 | 10 | 9 | 15 | 18 | 67 |
L2 | 11 | 25 | 26 | 73 | |||
L3 | 10 | 18 | 20 | 70 | |||
L4 | 10 | 19 | 20 | 68 | |||
L5 | 12 | 21 | 28 | 63 | |||
L6 | 10 | 16 | 20 | 60 | |||
L7 | 10 | 14 | 19 | 59 | |||
L8 | 10 | 13 | 19 | 56 | |||
L9 | 13 | 19 | 34 | 82 | |||
b | L1 | 10 × 7.5 | 0.01 | 13 | 23 | 33 | |
b | 10 × 100 | 10 | 13 | 24 | 34 | ||
galectin-328,b | O | 10 × 10 | 0.01 | 54 | 185 | 583 | |
M | 46 | 199 | 428 | ||||
P | 40 | 206 | 328 | ||||
O | 10 × 100 | 10 | 70 | 162 | 980 | ||
M | 70 | 174 | 990 | ||||
P | 60 | 208 | 714 | ||||
galectin-351 | Lac | 10 × 200 | 100 | 37 | 161 | 274 | 126 |
L02 | 30 | 152 | 177 | 122 | |||
Lac | 40 × 0.2 | 5 | 45 | 190 | 398 | 99 | |
L02 | 49 | 185 | 476 | 100 | |||
fXa50 | CBB | 40 × 0.2 | 5 | 66 | 154 | 880 | 114 |
C9 | 61 | 159 | 737 | 116 | |||
C39 | 40 | 119 | 321 | 116 | |||
C47 | 66 | 167 | 872 | 118 | |||
C49 | 69 | 208 | 949 | 119 | |||
C50 | 71 | 254 | 1009 | 119 | |||
C53 | 66 | 218 | 876 | 119 | |||
C57 | 41 | 113 | 333 | 115 | |||
C63 | 41 | 125 | 330 | 113 | |||
avidin41 | Btn1 | 4 × 25 × 0.2 | 5 | 48 | 166 | 469 | 102 |
Btn2 | 4 × 30 × 0.2 | 47 | 162 | 452 | 103 | ||
Btn3 | 4 × 20 × 0.2 | 50 | 213 | 495 | 100 | ||
Btn4 | 4 × 50 × 0.2 | 25 | 82 | 126 | 99 | ||
Btn5 | 4 × 40 × 0.2 | 25 | 48 | 123 | 78 | ||
Btn6 | 4 × 20 × 0.2 | 20 | 43 | 80 | 75 | ||
Btn7 | 4 × 20 × 0.2 | 21 | 53 | 91 | 66 | ||
Btn1 | 25 × 0.2 | 13 | 30 | 35 | 102 | ||
13 | 38 | 36 | 101 | ||||
14 | 46 | 40 | 101 | ||||
13 | 42 | 32 | 102 | ||||
Btn2 | 30 × 0.2 | 14 | 40 | 41 | 103 | ||
14 | 32 | 40 | 104 | ||||
15 | 40 | 44 | 102 | ||||
14 | 42 | 41 | 103 | ||||
Btn3 | 20 × 0.2 | 14 | 38 | 38 | 98 | ||
14 | 38 | 40 | 100 | ||||
15 | 39 | 43 | 101 | ||||
15 | 56 | 48 | 101 | ||||
Btn4 | 50 × 0.2 | 13 | 29 | 33 | 100 | ||
13 | 33 | 33 | 97 | ||||
13 | 38 | 36 | 99 | ||||
12 | 30 | 31 | 98 | ||||
Btn5 | 40 × 0.2 | 10 | 32 | 21 | 77 | ||
13 | 33 | 33 | 78 | ||||
13 | 38 | 36 | 78 | ||||
12 | 30 | 31 | 79 | ||||
Btn6 | 20 × 0.2 | 10 | 18 | 19 | 74 | ||
9 | 23 | 16 | 75 | ||||
10 | 18 | 18 | 75 | ||||
10 | 18 | 18 | 75 | ||||
Btn7 | 20 × 0.2 | 8 | 19 | 14 | 70 | ||
8 | 15 | 14 | 67 | ||||
8 | 17 | 13 | 64 | ||||
9 | 22 | 16 | 68 |
The table shows the protein, the ligand (named after the original publications), the length of the simulation (number of independent simulations times the length of the production simulation in ns; for avidin, an initial “4×” signifies that the four binding sites in the homotetrameric protein are considered at the same time) and the sampling frequency (f in fs).
Present investigation.